Healthcare Triangle Reports Third Quarter 2026 Results: Nine-Month Revenue Up 162% to $28.2 Million and Nine-Month Gross Margin Up 354%

AI-Powered Customer Engagement Segment Delivered $6.53 Million of Q3 Revenue at a 27.9% Gross Margin

PLEASANTON, Calif., Nov. 12, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, today reported financial results for the third quarter and nine months ended September 30, 2026. Revenue for the nine months rose 162% to $28.16 million, while gross profit grew 354% to $6.54 million, lifting gross margin to 23.2% from 13.4%. In the third quarter, revenue increased 161% to $9.12 million and gross profit increased 237% to $2.08 million, while loss from operations narrowed to 21.9% of revenue from 74.3% a year ago. The Company's AI-powered Customer Engagement Services segment delivered approximately 72% of third quarter revenue and was the primary driver of the increase in gross margin to 22.8% from 17.7%.

Building on the momentum from the first half of the year, the Company's results reflect the transformative impact of its subsidiaries Teyame 360 S.L. ("Teyame 360") and Datono Mediacion S.L. ("Datono," and together with Teyame 360, "Teyame"), which contributed to a third consecutive quarter of triple-digit revenue and gross profit growth.

Third Quarter and Nine-Month 2026 Highlights

Revenue growth: Nine-month revenue of $28.16 million, up 162%. Third quarter revenue of $9.12 million, up 161%, marking a third consecutive quarter of triple-digit growth.

Gross profit outpacing revenue: Nine-month gross profit of $6.54 million, up 354%, with gross margin expanding 9.8 points to 23.2%. Third quarter gross profit of $2.08 million, up 237%, with gross margin of 22.8%, up from 17.7% a year ago and 22.5% in the second quarter of 2026.

Customer Engagement Services: Segment revenue of $6.53 million, up from $6.31 million in the second quarter, at a 27.9% gross margin, up from 26.1%, contributing $1.82 million of gross profit.

Nine Months Ended September 30, 2026 Financial Highlights

Q3 2026 Financial Highlights

Customer Engagement Services (Teyame): Scaling Revenue and Expanding Margins

Teyame remained the primary driver of HCTI's financial performance in the third quarter. The acquired businesses, which operate as an integrated AI-powered omnichannel customer experience, marketing, and financial and insurance distribution platform and are reported as the Company's Customer Engagement Services segment, contributed $6.53 million of revenue during the quarter, up from $6.31 million in the second quarter and representing approximately 72% of the Company's total Q3 2026 revenue.

The segment generated $1.82 million in gross profit at a gross margin of approximately 27.9%, above the Company's historical margin profile and up from approximately 26.1% in the second quarter. The continued strength of this segment remained the key driver behind the Company's overall gross margin expansion, from 17.7% in Q3 2025 to 22.8% in Q3 2026 and from 13.4% to 23.2% for the nine months. Management expects gross margin to continue to improve as new contracts are negotiated at higher margins.

David Ayanoglou, Chief Financial Officer of Healthcare Triangle, said:

"Our third quarter and nine-month results show that the performance we saw following the Teyame and Datono acquisition continues to improve. Revenue has more than doubled, gross profit has grown 354%. The Customer Engagement Services segment contributed $6.53 million in revenue and $1.82 million in gross profit during the quarter, and our Company-wide gross margin has expanded to 23.2% for the nine months from 13.4%. This is why we believe we are well positioned to continue building a diversified, AI-driven technology portfolio." 

About Healthcare Triangle

Healthcare Triangle, Inc., based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle has achieved HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.

About Teyame

Teyame AI Holdings Inc., operating through its subsidiaries Teyame 360 SL and Datono Mediacion SL, is a Spain-based customer experience company offering a results-driven marketing and telemarketing omni-channel platform. With offices in Madrid, Barcelona, and Malaga, Teyame designs and manages omnichannel campaigns that combine artificial intelligence, custom-built applications, and data-driven strategy to help clients optimize their databases, generate and convert leads, and strengthen customer relationships. Its service portfolio spans lead generation, customer satisfaction surveys, debt management, inbound and outbound call campaigns, cross-selling, and web and media services, with a strong emphasis on giving clients real-time visibility and control over their campaigns.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the Company's future financial and operating performance, the anticipated benefits of the Teyame and Datono acquisition, expected gross margin trends, and expected trends in the Company's business. Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "believe," "will," "continue," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions, the Company's history of net losses and negative operating cash flows, customer concentration (the top five customers represented 58% of third quarter revenue), the Company's ability to integrate acquired businesses, its ability to maintain its Nasdaq listing, the outcome of the pending claim by L1 Capital Global Opportunities Master Fund Ltd. relating to warrant adjustments, and dilution from and availability of equity financing. Actual results could differ materially from current projections or implied results. Investors should read the risk factors outlined in the Company's annual report on Form 10-K for the year ended December 31, 2025, as amended, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, on file with the Securities and Exchange Commission (the "SEC") and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Investors
1-800-617-9550
[email protected]

SOURCE Healthcare Triangle, Inc.